相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is It Possible to Develop a Universal Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine
Florian Krammer et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs
Bao Danqi et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Strategies to induce broadly protective antibody responses to viral glycoproteins
F. Krammer
EXPERT REVIEW OF VACCINES (2017)
Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China
Fuchun Zhang et al.
JOURNAL OF INFECTION (2017)
Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans
Lu Liu et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Affinity of human IgG subclasses to mouse Fc gamma receptors
Gillian Dekkers et al.
MABS (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
Lisa M. Dunkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial
John J. Treanor et al.
VACCINE (2017)
Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016
Dong-Hun Lee et al.
VIROLOGY (2017)
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
Henning Jacobsen et al.
MBIO (2017)
Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017
A. Danielle Iuliano et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial
Adam D. DeZure et al.
NPJ VACCINES (2017)
Towards an evidence based approach for the development of adjuvanted vaccines
Derek T. O'Hagan et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans
Sarah F. Andrews et al.
SCIENCE IMMUNOLOGY (2017)
First Detection of Avian Lineage H7N2 in Felis catus
Sandra P. Newbury et al.
GENOME ANNOUNCEMENTS (2017)
Universal influenza virus vaccines and therapeutic antibodies
R. Nachbagauer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
Raffael Nachbagauer et al.
NATURE IMMUNOLOGY (2017)
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
Mahdee Sobhanie et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection
Carole J. Henry Dunand et al.
CELL HOST & MICROBE (2016)
Two Outbreak Sources of Influenza A (H7N9) Viruses Have Been Established in China
Dayan Wang et al.
JOURNAL OF VIROLOGY (2016)
H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
Larisa Rudenko et al.
LANCET INFECTIOUS DISEASES (2016)
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
Carole J. Henry Dunand et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine
Jessica L. Halliley et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Advances in the development of influenza virus vaccines
Florian Krammer et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
MBIO (2015)
Family Clusters of Avian Influenza A H7N9 Virus Infection in Guangdong Province, China
Lina Yi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Co-infection with Avian (H7N9) and Pandemic (H1N1) 2009 Influenza Viruses, China
Wanju Zhang et al.
EMERGING INFECTIOUS DISEASES (2015)
An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
Florian Krammer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant A Randomized Clinical Trial
Mark J. Mulligan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
Raffael Nachbagauer et al.
JOURNAL OF VIROLOGY (2014)
Characterization of a Broadly Neutralizing Monoclonal Antibody That Targets the Fusion Domain of Group 2 Influenza A Virus Hemagglutinin
Gene S. Tan et al.
JOURNAL OF VIROLOGY (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo-Controlled, Randomized Double-Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine
Larisa Rudenko et al.
PLOS ONE (2014)
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
Ali H. Ellebedy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine
Tara M. Babu et al.
VACCINE (2014)
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
Javier G. Magadan et al.
PLOS PATHOGENS (2014)
Human Co-Infection with Avian and Seasonal Influenza Viruses, China
Jun Li et al.
EMERGING INFECTIOUS DISEASES (2014)
Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013
Li Guo et al.
EMERGING INFECTIOUS DISEASES (2014)
The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines
Florian Krammer et al.
EXPERT REVIEW OF VACCINES (2013)
Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
Christopher B. Fox et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9)
Michael T. Osterholm et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms
Yanming An et al.
JOURNAL OF PROTEOME RESEARCH (2013)
H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
Irina Margine et al.
JOURNAL OF VIROLOGY (2013)
A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
Louis F. Fries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Rongbao Gao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs
H. Zhu et al.
SCIENCE (2013)
Structures and Receptor Binding of Hemagglutinins from Human-Infecting H7N9 Influenza Viruses
Yi Shi et al.
SCIENCE (2013)
The Novel Human Influenza A(H7N9) Virus Is Naturally Adapted to Efficient Growth in Human Lung Tissue
Jessica Knepper et al.
MBIO (2013)
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility
Rong Hai et al.
NATURE COMMUNICATIONS (2013)
Correlates of protection to influenza virus, where do we go from here?
Rebecca J. Cox
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
Irina Margine et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
A Carboxy-Terminal Trimerization Domain Stabilizes Conformational Epitopes on the Stalk Domain of Soluble Recombinant Hemagglutinin Substrates
Florian Krammer et al.
PLOS ONE (2012)
A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
Robert B. Couch et al.
PLOS ONE (2012)
Highly Conserved Protective Epitopes on Influenza B Viruses
Cyrille Dreyfus et al.
SCIENCE (2012)
A fast track influenza virus vaccine produced in insect cells
Manon M. J. Cox et al.
JOURNAL OF INVERTEBRATE PATHOLOGY (2011)
Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies
Masanori Terajima et al.
JOURNAL OF VIROLOGY (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
Rebecca J. Cox et al.
VACCINE (2009)
分享论文
